The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Knopf, H. P.
Right arrow Articles by Schumann, R. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Knopf, H. P.
Right arrow Articles by Schumann, R. R.

The Journal of Immunology, Vol 153, Issue 1 287-299, Copyright © 1994 by American Association of Immunologists


ARTICLES

Discordant adaptation of human peritoneal macrophages to stimulation by lipopolysaccharide and the synthetic lipid A analogue SDZ MRL 953. Down- regulation of TNF-alpha and IL-6 is paralleled by an up-regulation of IL-1 beta and granulocyte colony-stimulating factor expression

HP Knopf, F Otto, R Engelhardt, MA Freudenberg, C Galanos, F Herrmann and RR Schumann
Department of Internal Medicine I, Freiburg University Medical Center, Germany.

Human peritoneal macrophages were exposed to increasing doses of LPS or a synthetic lipid A analogue (SDZ MRL 953) and production of the cytokines IL-1 beta, IL-6, TNF-alpha, and G-CSF was assessed at the protein and mRNA level. Cells were also prestimulated with low doses of LPS and SDZ MRL 953 to study their adaptation to a secondary challenge with high doses of LPS. The ability of macrophages to produce high levels of TNF-alpha and IL-6 after stimulation with LPS could be relieved almost completely by preincubating cells with low doses of LPS. Decreases of TNF-alpha and IL-6 production resulted from inhibition of gene transcription and/or changes in mRNA stability, as transcript levels of these cytokines were down-modulated by the process of LPS adaptation. Surprisingly, however, adapted cells were able to synthesize even larger quantities of G-CSF and IL-1 beta when exposed to a secondary LPS challenge. mRNA levels of the adapted cells remained unaltered for IL-1 beta, but were slightly increased for G-CSF as assessed by Northern blot analysis. High doses of the synthetic lipid A analogue SDZ MRL 953 were also able to adapt macrophages to a secondary LPS challenge by down-regulating TNF-alpha and IL-6 production, whereas priming secretion of G-CSF and IL-1 beta as well. We describe here the discordant adaptation of human peritoneal macrophages to a secondary LPS stimulus in vitro. These findings appear to have ramifications for the in vivo endotoxin response during inflammation and also Gram- negative septicemia.


This article has been cited by other articles:


Home page
J. Immunol.Home page
R. D. Stout, C. Jiang, B. Matta, I. Tietzel, S. K. Watkins, and J. Suttles
Macrophages Sequentially Change Their Functional Phenotype in Response to Changes in Microenvironmental Influences
J. Immunol., July 1, 2005; 175(1): 342 - 349.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
L. Hamann, C. Alexander, C. Stamme, U. Zahringer, and R. R. Schumann
Acute-Phase Concentrations of Lipopolysaccharide (LPS)-Binding Protein Inhibit Innate Immune Cell Activation by Different LPS Chemotypes via Different Mechanisms
Infect. Immun., January 1, 2005; 73(1): 193 - 200.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. D. Lehner, S. Morath, K. S. Michelsen, R. R. Schumann, and T. Hartung
Induction of Cross-Tolerance by Lipopolysaccharide and Highly Purified Lipoteichoic Acid Via Different Toll-Like Receptors Independent of Paracrine Mediators
J. Immunol., April 15, 2001; 166(8): 5161 - 5167.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Merlin, A. Sing, P. J. Nielsen, C. Galanos, and M. A. Freudenberg
Inherited IL-12 Unresponsiveness Contributes to the High LPS Resistance of the Lpsd C57BL/10ScCr Mouse
J. Immunol., January 1, 2001; 166(1): 566 - 573.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
A. Sing, T. Merlin, H.-P. Knopf, P. J. Nielsen, H. Loppnow, C. Galanos, and M. A. Freudenberg
Bacterial Induction of Beta Interferon in Mice Is a Function of the Lipopolysaccharide Component
Infect. Immun., March 1, 2000; 68(3): 1600 - 1607.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
H. Shimauchi, T. Ogawa, K. Okuda, Y. Kusumoto, and H. Okada
Autoregulatory Effect of Interleukin-10 on Proinflammatory Cytokine Production by Porphyromonas gingivalis Lipopolysaccharide-Tolerant Human Monocytes
Infect. Immun., May 1, 1999; 67(5): 2153 - 2159.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
V. K. Tam, S. Schotland, and J. Green
Inflammatory cytokines (IL-1alpha , TNF-alpha ) and LPS modulate the Ca2+ signaling pathway in osteoblasts
Am J Physiol Cell Physiol, June 1, 1998; 274(6): C1686 - C1698.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. Roth, T. Aslan, B. Storr, and E. Zeisberger
Lack of cross tolerance between LPS and muramyl dipeptide in induction of circulating TNF-alpha and IL-6 in guinea pigs
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 1997; 273(4): R1529 - R1533.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Kiani, A. Tschiersch, E. Gaboriau, F. Otto, A. Seiz, H.-P. Knopf, P. Stutz, L. Farber, U. Haus, C. Galanos, et al.
Downregulation of the Proinflammatory Cytokine Response to Endotoxin by Pretreatment With the Nontoxic Lipid A Analog SDZ MRL 953 in Cancer Patients
Blood, August 15, 1997; 90(4): 1673 - 1683.
[Abstract] [Full Text] [PDF]


Home page
Innate ImmunityHome page
D. Schilling, J. Brauburger, W. Ruiner, and K. Nixdorff
Modulation of interleukin 1 production in macrophages stimulated with lipopolysaccharide by the protein kinase inhibitor staurosporine
Innate Immunity, August 1, 1997; 4(4): 251 - 260.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1994 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1994 by The American Association of Immunologists, Inc. All rights reserved.